iShares LifePath Target Date 2035 ETF (NYSEARCA:ITDC – Get Free Report) shot up 0.6% during mid-day trading on Wednesday . The company traded as high as $30.38 and last traded at $30.34. 11,355 shares changed hands during trading, an increase of 51% from the average session volume of 7,510 shares. The stock had previously closed at $30.17.
iShares LifePath Target Date 2035 ETF Stock Performance
The business has a 50 day simple moving average of $30.42 and a 200-day simple moving average of $30.59. The stock has a market capitalization of $26.09 million, a P/E ratio of 21.64 and a beta of 0.72.
Hedge Funds Weigh In On iShares LifePath Target Date 2035 ETF
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Heck Capital Advisors LLC bought a new position in iShares LifePath Target Date 2035 ETF during the 4th quarter valued at $46,000. Cyr Financial Inc. bought a new position in iShares LifePath Target Date 2035 ETF during the 4th quarter valued at $299,000. Finally, Citadel Advisors LLC bought a new position in iShares LifePath Target Date 2035 ETF during the 4th quarter valued at $208,000.
iShares LifePath Target Date 2035 ETF Company Profile
The iShares LifePath Target Date 2035 ETF USD (ITDC) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches.
Further Reading
- Five stocks we like better than iShares LifePath Target Date 2035 ETF
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Alphabet’s Officially In A Bear Market—Time To Buy?
- What Are Dividend Challengers?
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for iShares LifePath Target Date 2035 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2035 ETF and related companies with MarketBeat.com's FREE daily email newsletter.